John Montana

Chief Executive Officer at

Oxitope Pharma BV

Commercial Services

Health Technology

Consumer Services

Profile

John Montana is currently a Non-Executive Director at Metrion Biosciences Ltd., a Director, Chief Executive & Operating Officer at Oxitope Pharma BV, and an Operating Partner at Forbion Capital Partners Management Holding BV.
Previously, he held positions as a Director & Chief Scientific Officer at Pulmagen Therapeutics (Synergy) Ltd., Vice President-Integrated Drug Discovery at Charles River Laboratories International, Inc., Principal at Chiroscience Group Plc, Principal at Paradigm Therapeutics Ltd., and Principal at Glaxo, Inc. Dr. Montana obtained his undergraduate degree from The University of Manchester in 1983 and his doctorate degree from the University of East Anglia in 1987.

John Montana active positions

Companies	Position	Start
Metrion Biosciences Ltd. Metrion Biosciences Ltd. BiotechnologyHealth Technology Engages in research and development of ion channel drugs	Director/Board Member	09/02/2021
Oxitope Pharma BV Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Manufactures medicines for the treatment of inflammatory and cardiovascular diseases	Chief Executive Officer	-
Forbion Capital Partners Management Holding BV Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor.	Private Equity Investor	01/01/2020

All active positions of John Montana

Former positions of John Montana

Companies	Position	End
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Corporate Officer/Principal	-
Glaxo, Inc.	Corporate Officer/Principal	-
Paradigm Therapeutics Ltd. Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Corporate Officer/Principal	-
Chiroscience Group Plc Chiroscience Group Plc Miscellaneous Commercial ServicesCommercial Services Research based pharmaceutical group	Corporate Officer/Principal	-
Pulmagen Therapeutics (Synergy) Ltd. Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for respiratory diseases	Chief Tech/Sci/R&D Officer	-

See the detail of John Montana's experience

Training of John Montana

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Montana's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Charles River Laboratories International, Inc. Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis	Commercial Services
The University of Manchester The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Chiroscience Group Plc Chiroscience Group Plc Miscellaneous Commercial ServicesCommercial Services Research based pharmaceutical group	Commercial Services
Pulmagen Therapeutics (Synergy) Ltd. Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for respiratory diseases	Commercial Services
Paradigm Therapeutics Ltd. Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
University of East Anglia University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Forbion Capital Partners Management Holding BV Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor.	Finance
Glaxo, Inc.
Metrion Biosciences Ltd. Metrion Biosciences Ltd. BiotechnologyHealth Technology Engages in research and development of ion channel drugs	Health Technology
Oxitope Pharma BV Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Manufactures medicines for the treatment of inflammatory and cardiovascular diseases	Health Technology